Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Chemical Research in Toxicology|September 12, 2009
Natural polyphenols as direct trapping agents of lipid peroxidation-derived acrolein and 4-hydroxy-trans-2-nonenalQin Zhu, Zong-Ping Zheng, Ka-Wing Cheng, et al.
Chemical Research in Toxicology|March 19, 2010
Direct trapping of acrylamide as a key mechanism for niacin's inhibitory activity in carcinogenic acrylamide formationXiaohui Zeng, Ricky P W Kong, Ka-Wing Cheng, et al.
European Journal of Medicinal Chemistry|May 14, 2025
Novel benzamide derivatives with indole moiety as dual-target antiviral agents: Rational design, efficient synthesis, and potent anti-influenza activity through concurrent binding to PA<sub>C</sub> terminal domain and viral nucleoproteinChao Zhang, Jia-Bin Li, Yi-Wen Zhang, et al.
Nature Communications|November 26, 2025
Characterization of two non-competing antibodies to influenza H3N2 hemagglutinin stem reveals its evolving antigenicityAkshita B Gopal, Huibin Lv, Tossapol Pholcharee, et al.
The Journal of Infection|December 10, 2024
Comparison of safety and immunogenicity in the elderly after receiving either Comirnaty or Spikevax monovalent XBB1.5 COVID-19 vaccineChris Ka Pun Mok, Yun Sang Tang, Chee Wah Tan, et al.
Vaccine|April 30, 2026
Robust cross-neutralizing antibody responses but variable cellular immunity following either Comirnaty and Spikevax JN.1-adapted mRNA vaccination in the elderlyYun Sang Tang, Chunke Chen, Huibin Lv, et al.
European Journal of Medicinal Chemistry|December 2, 2025
Discovery of imidazo[1,2-a]pyridine derivatives as potent anti-influenza agents: SPR affinity-based screening and structure-activity relationship studyChao Zhang, Yun-Sang Tang, Jian-Fei Gao, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 19, 2024
Determination of T cell response against XBB variants in adults who received either monovalent wild-type inactivated whole virus or mRNA vaccine or bivalent WT/BA.4-5 COVID-19 mRNA vaccine as the additional boosterYun Sang Tang, Chee Wah Tan, Ka Chun Chong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 13, 2026
Somatic Evolution of a Germline Antibody Expands its Breadth to Neutralize Early SARS-CoV-2 Omicron VariantsHuibin Lv, Ziqi Feng, Qi Wen Teo, et al.
Cell Host & Microbe|October 18, 2025
Evolution of antibody cross-reactivity to influenza H5N1 neuraminidase from an N2-specific germlineHuibin Lv, Yang Wei Huan, Qi Wen Teo, et al.
Pageof 4